Vulvar cancer

Common Name(s)

Vulvar cancer

Vulvar cancer is the abnormal growth of cells of the vulva, which is part of the female reproductive system and includes the vaginal lips, clitoris, and part of the vagina.  Symptoms of vulvar cancer may consist of a lump (mass), itching, or unusual bleeding.  Though the exact cause of this cancer is unknown, older women and those who have human papillomavirus have a higher chance of developing vulvar cancer.  Treatment may include laser therapy, surgery, chemotherapy, or radiation therapy.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Vulvar cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Vulvar cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Vulvar cancer" returned 95 free, full-text research articles on human participants. First 3 results:

Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article.
 

Author(s): Yizhen Niu, Rutie Yin, Danqing Wang, Qingli Li, Xiu Gao, Meimei Huang

Journal: Medicine (Baltimore). 2018 Aug;97(34):e11786.

 

To investigate the effect of neoadjuvant chemotherapy in patients with advanced vulvar cancer and to provide references for clinical treatment.Clinical and pathological data of 12 patients with advanced vulvar carcinoma were collected. The response and operability rates, adverse effects, ...

Last Updated: 31 Dec 1969

Go To URL
Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
 

Author(s): Sebastian Zięba, Artur Kowalik, Kamil Zalewski, Natalia Rusetska, Krzysztof Goryca, Agata Piaścik, Marcin Misiek, Elwira Bakuła-Zalewska, Janusz Kopczyński, Kamil Kowalski, Jakub Radziszewski, Mariusz Bidziński, Stanisław Góźdź, Magdalena Kowalewska

Journal: Gynecol. Oncol.. 2018 09;150(3):552-561.

 

Vulvar squamous cell carcinoma (VSCC) constitutes over 90% of vulvar cancer. Its pathogenesis can follow two different pathways; high risk human papillomavirus (hrHPV)-dependent and HPV-independent. Due to the rarity of VSCC, molecular mechanisms underlying VSCC development remain ...

Last Updated: 31 Dec 1969

Go To URL
ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.
 

Author(s): Céline Montavon Sartorius, Andreas Schoetzau, Henriette Kettelhack, Daniel Fink, Neville F Hacker, André Fedier, Francis Jacob, Viola Heinzelmann-Schwarz

Journal:

 

The relationship between ABO blood groups (BG) and risk of incidence in cancers including gynecological cancers has been widely studied, showing increased incidence risk for BG A patients. As available data are inconsistent we investigated whether BG and their anti-glycan antibodies ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Vulvar cancer" returned 10 free, full-text review articles on human participants. First 3 results:

Incidence of lower limb lymphedema after vulvar cancer: A systematic review and meta-analysis.
 

Author(s): Jiuzuo Huang, Nanze Yu, Xiaojun Wang, Xiao Long

Journal: Medicine (Baltimore). 2017 Nov;96(46):e8722.

 

Lower limb lymphedema (LLL) is an important concern for patients with vulvar cancer. Studies of the incidence of vulvar cancer-related lymphedema and its risk factors have substantially increased in the new millennium.

Last Updated: 31 Dec 1969

Go To URL
A cohort study of vulvar cancer over a period of 10 years and review of literature.
 

Author(s): N Singh, N Negi, K Srivastava, G Agarwal

Journal: Indian J Cancer. ;53(3):412-415.

 

The objective of this study was to study the risk factors, management protocols, and the outcome of vulvar cancer cases over a period of 10 years in a tertiary care hospital.

Last Updated: 31 Dec 1969

Go To URL
Feasibility and Safety of Video Endoscopic Inguinal Lymphadenectomy in Vulvar Cancer: A Systematic Review.
 

Author(s): Chai-E Liu, Yan Lu, De-Sheng Yao

Journal:

 

To systematically review previous studies and to evaluate the feasibility and safety of video endoscopic inguinal lymphadenectomy (VEIL) in vulvar cancer.

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

New Strategy for the Treatment of Vulvar Cancer
 

Status: Recruiting

Condition Summary: Vulvar Neoplasm

 

Last Updated: 14 Sep 2018

Go to URL
The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer
 

Status: Recruiting

Condition Summary: Vulvar Cancer, G9a Protein

 

Last Updated: 2 Oct 2018

Go to URL